This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Travis Young
Introduction
Travis Young is a notable inventor based in Galveston, Texas. He has made significant contributions to the field of cancer research, particularly in understanding the role of tumor susceptibility gene 101 (TSG 101) in ovarian cancer. His work has implications for both diagnostics and therapeutics in oncology.
Latest Patents
Travis Young holds a patent for the use of tumor susceptibility gene 101 (TSG 101) as a prognostic and diagnostic marker. This invention reveals the connection between oncogenic Ras and TSG101, highlighting the negative impact of TSG101 on the expression of p21 in ovarian cancer. The patent emphasizes the potential of TSG101 as a prognostic and diagnostic marker, as well as a therapeutic target in cancer treatment.
Career Highlights
Travis Young is affiliated with the University of Texas System, where he conducts his research. His work has garnered attention for its innovative approach to cancer diagnostics and treatment. With a focus on ovarian cancer, his research aims to improve patient outcomes through better understanding and utilization of genetic markers.
Collaborations
Travis has collaborated with esteemed colleagues such as Xiaodong Cheng and Fang Mel. These partnerships enhance the depth and breadth of his research, contributing to advancements in the field of cancer biology.
Conclusion
Travis Young's contributions to cancer research through his patent on TSG 101 exemplify the importance of innovation in medical science. His work not only advances our understanding of ovarian cancer but also opens new avenues for diagnosis and treatment.